|
|
||||||||
Clinical Chemistry, Vol 38, 663-670, Copyright © 1992 by American Association for Clinical Chemistry
PM Crofton
Department of Paediatric Biochemistry, Royal Hospital for Sick Children, Edinburgh, U.K.
This modified lectin affinity electrophoresis method is suitable for simultaneous measurement of liver, bone, and high-molecular-mass (high- Mr) isoforms of alkaline phosphatase (ALP; EC 3.1.3.1) in children. Age- related isoform reference ranges were derived for 247 children, ages 0- 13 years. Liver ALP did not appear in plasma until after six months of age, and remained constant after one year of age. Bone ALP was highest in the youngest age group, and declined to relatively constant activities thereafter. High-MrALP was not detected in normal children. In bone disease, the bone isoform was increased in all age groups. In liver disease, only 5 of 30 infants younger than six months had detectable liver ALP, although half had increased bone ALP. Among children older than six months, 5 patients with biliary atresia and 15 patients with hepatitis A all had increased liver isoform activity. Liver ALP was also a sensitive index of early hepatobiliary complications in 27 nonjaundiced children with cystic fibrosis. Measurement of ALP isoforms therefore yields useful clinical information in children older than six months but is of doubtful value in younger infants.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Mayo, H. Macintyre, A. M. Wallace, and S. F. Ahmed Transdermal Testosterone Application: Pharmacokinetics and Effects on Pubertal Status, Short-Term Growth, and Bone Turnover J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Crofton, N. Evans, and R. Stephen Serum CrossLaps Compared with Other Markers of Bone Turnover in Severely Malnourished Children before and after Refeeding Clin. Chem., January 1, 2003; 49(1): 192 - 195. [Full Text] [PDF] |
||||
![]() |
G. Durand and N. Seta Protein Glycosylation and Diseases: Blood and Urinary Oligosaccharides as Markers for Diagnosis and Therapeutic Monitoring Clin. Chem., June 1, 2000; 46(6): 795 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Crofton, S. F. Ahmed, J. C. Wade, R. Stephen, M. W. Elmlinger, M. B. Ranke, C. J. H. Kelnar, and W. H. B. Wallace Effects of Intensive Chemotherapy on Bone and Collagen Turnover and the Growth Hormone Axis in Children with Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3121 - 3129. [Abstract] [Full Text] |
||||
![]() |
P. M. Crofton, J. C. Wade, M. R. H. Taylor, and C. V. Holland Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren Clin. Chem., September 1, 1997; 43(9): 1577 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tobiume, S. Kanzaki, S. Hida, T. Ono, T. Moriwake, S. Yamauchi, H. Tanaka, and Y. Seino Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2056 - 2061. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |